LifePak Wysokiej jakości suplement zawierający pełny zestaw wielu składników odżywczych Podsumowanie



Pobieranie 211.12 Kb.
Strona5/5
Data07.05.2016
Rozmiar211.12 Kb.
1   2   3   4   5
Chiu K. M., Efficacy of calcium supplementation on bone mass in postmenopausal women, J. Gerontol. [A], 1999; 54: M275-M280

  • Looker A. C., Harris T. B., Madans J. H., Sempos C. T., Dietary calcium and hip fracture risk: the NHANES I Epidemiologic Follow-up Study, Osteoporos. Int., 1993; 3: 4-84

  • Power M. L., Heancy R. P., Kalkwarf H. J., et al., The role of calcium in health and disease, Am. J. Obstet. Gynecol., 1999; 181: 1560-9

  • Reid I. R., The roles of calcium and vitamin D in the prevention of osteoporosis, Endocrinol. Metab. Clin. North. Am., 1998; 27: 389-98

  • Food and Nutrition Board and Institute of Medicine, Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride, Prepublication copy, 1997, Washington D.C., National Academy Press

  • Sojka J. E., Weaver C. M., Magnesium supplementation and osteoporosis, Nutr. Rev., 1995; 53: 71-4

  • Stendig-Lindberg G., Tepper R., Leichter I., Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis, Magnes. Res., 1993; 6: 155-163

  • Paunier L., Effect of magnesium on phosphorus and calcium metabolism, Monatsschr. Kinderheilkd., 1992; 140: S17-S20

  • Patti L., Maffettone A., Iovine C., et al., Long-term effects of fish oil on lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia, Atherosclerosis, 1999; 146: 361-7

  • Volpe S. L., taper L. J., Mcacham S., The relationship between boron and magnesium status and bone density in the human: a review, Magnes. Res., 1993; 6: 291-6

  • Martini L. A., Magnesium supplemantation and bone turnover, Nutr. Rev., 1999; 57: 227-9

  • Gallagher J. C., The role of vitamin D in the pathogenesis and treatment of ostoporosis, J. Rheumatol. Suppl., 1996; 45: 15-8

  • Boullion R. A., Auerx J. H., Lissens W. D., Pelmans W. K., Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency, Am. J. Clin. Nutr., 1987; 45: 755-63

  • Diamond T., Smerdely P., Kormas N., Sekel R., Vu T., Day P., Hip fracture in elderly men: the importance of subclinical vitamin D deficiency and hypogonadism, Med. J. Aust., 1998; 169: 138-41

  • Torgeson D. J., Kanis J. A., Cost-effectiveness of preventing hip fracture in the elderly population using vitamin D and calcium, Q. J. Med., 1995; 88: 135-9

  • Ooms M. E., Roos J. C., Bezemer P. D., van der Vijgh W. J., Bouter L. M., Lips P., Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial, J. Clin. Endocrinol. Metab., 1995; 80: 1052-8

  • O’Brien K. O., Combined calcium and vitamin D supplementation reduces bone loss and fracture incidence in older men and women, Nutr. Rev., 1998; 56: 148-50

  • Kaufamn J. M., Role of calcium and vitamin D in the prevention and the treatment of postmenopausal osteoporosis: an overview, Clin. Rheumatol., 1995; 14 Suppl. 3: 9-13

  • Gloth F. M., Gunderberg C. M., Hollis B. W., Haddad J. G.Jr., Tobin J. D., Vitamin D deficiency in homebound elderly persons, JAMA, 1995; 274: 1683-6

  • Kessenich C. R., Rosen C. J., Vitamin D and bone status in elderly women, Orthop. Nurs., 1996; 15: 67-71

  • Holick M. F., Environmental factors that influence the cutanous production of vitamin D, Am. J. Clin. Nutr., 1995; 61: Suppl.: 638S-645S

  • Blinkey N. C., Suttie J. W., Vitamin K nutrition and osteoporosis, J. Nutr., 1995; 125: 1812-21

  • Vermeer C., Jie K. S. G., Knapen M. H. J., Role of vitamin K in bone metabolism, Ann. Rev. Nutr., 1995; 15: 1-22

  • Dowd P., Ham S. W., Naganathan S., Hershline R., The mechanism of action of vitamin K, Annu. Rev. Nutr., 1995; 15: 419-40

  • Ferland G., The vitamin K-dependent proteins: an update, Nutr. Rev., 1998; 56: 223-30

  • Porter K. H., Undercarboxylated ostocalcin: Indicator of vitamin K status and hip fracture risk?, Biochem. Arch., 1999; 15: 225-37

  • Vermeer G., Schurgers L. J., A comprehensive review of vitamin K and vitamin K antagonists, Hematol. Oncol. Clin. North Am., 2000; 14: 339-53

  • Nielsen F. H., Biochemical and physiological consequences of boron deprivation in humans, Environ. Health Perspect., 1994; 102 Suppl. 7: 59-63

  • Naghii M. R., Samman S., The role of boron in nutrition and metabolism, Prog. Food Nutr. Sci., 1993; 17: 331-49

  • McCoy H., Kenney M. A., Montgomery C., Irwin A., Williams L., Orrelli R., Relation of boron to the composition and mechanical properties of bone, Environ. Health Perspect., 1994; 102 Suppl. 7: 49-53

  • Nielsen F. H., Ultratrace elements. In: Shils M. E., Olson J. A., Shike M., eds., Modern Nutrition in Health and Disease, Philadelphia: Lea & Febiger, 1994: 269-86

  • Newnham R. E., Essentiality of boron for healthy bones and joints, Environ. Health Perspect., 1994; 102 Suppl. 7: 83-5

  • Dupre J. N., Keenan M. J., Hegsted M., Brudevold A. M., Effects of dietary boron in rats fed a vitamin D-deficient diet, Environ. Health Perspect., 1994; 102 Suppl. 7:55-8

  • Hunt C. D., The biochemical effects of physiologic amounts of dietary boron in animal nutrition models, Environ. Helath Perspect., 1994; 102 Suppl. 7: 35-43

  • Mcacham S. L., Taper L. J., Volpe S. L., Effect of boron supplementation on blood and urinary calcium, magnesium, and phosphorus, and urinary boron in athletic and sedentary women, Am. J. Clin. Nutr., 1995; 61: 341-5

  • Mcacham S. L., Taper L. J., Volpe S. L., Effects of boron on bone mineral density and dietary, blood, and urinary calcium, phosphorus, magnesium, and boron in female athletes, Environ. Health Perspect., 1994, 102 Suppl. 7: 79-82

  • Nielsen F. H., Shuler T. R., Studies of the interaction between boron and calcium, and its modification by magnesium and potassium, in rats. Effects on growth, blood variables, and bone mineral composition, Biol. Trace Elem. Res., 1992; 35: 225-37

  • Hegsted M., Keenen M. J., Siver F., Wozniak P., Effect of boron on vitamin D deficient rats, Biol. Trace Elem. Res., 1991; 28: 243-55

  • Nielsen F. H., Studies on the relationship between boron and magnesium in the formation and maintenance of bones, J. Am. Coll. Nutr., 1989; 8: 457 (abstr)

  • Seaborn C. D. N. F., Silicon: A nutrional beneficence for bones, brains and blood vessels?, Nutrition Today, 1993; 28: 13-6

  • Nielsen F. H., Ultratrace elements in nutrition: Current knowledge and speculation, J. Trace Elem. Exp. Med., 1998; 11: 251-74

  • Carlisle E. M., Silicon as a trace nutrient, Sci. Total Environ., 1988; 73: 95-106

  • Seaborn C. D., Nielsen F. H., Effects of germanium and silicon on bone mineralization, Biol. Trace Elem. Res., 1994; 42: 151-164

  • Seaborn C. D., Bielsen F. H., Response surface analysis of bone composition changes caused by dietary calcium and silicon, FASEB J., 1993; 7: A77

  • Rico H., Gallego-Lago J. L., Hernández E. R., et al., Effect of silicon supplement on osteopenia induced by ovariectomy in rats, Cacified Tissue International, 2000; 66: 53-5

  • Anderson J. J., Garner S. C., The effects of phytoestrogens on bone, Nutr. Res., 1997; 17: 1617-32

  • Potter S. M., Baum J. A., Teng H. Y., Stillman R. J., Shay N. F., Erdman J. W. Jr., Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women, Am. J. Clin. Nutr., 1998; 1375S-9S

  • Mertz W., Chromium in human nutrition: a review, J. Nutr., 1993; 123: 626-33

  • Anderson R. A., Chromium, glocose intolerance, and diabetes, J. Am. Coll. Nutr., 1998; 17: 548-55

  • Vincent J. B., Mechanisms of chromium action: Low-molecular-weight chromium-binding substance, J. Am. Coll. Nutr., 1999; 18: 6-12

  • Freund H., Atamian S., Fischer J. E., Chromium deficiency during total parenteral nutrition, JAMA, 1979: 241: 496-8

  • Jeejeebhoy K. N., Chu R. C., Marliss E. B., Greenberg G. R., Bruce-Robertson A., Chromium deficiency, glocose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition, Am. J. Clin. Nutr., 1977; 30: 531-8

  • Brown R. O., Forloines-Lynn S., Cross R. E., Heizer W. D., Chromium deficiency after long-term total parenteral nutrition, Dig. Dis. Sci., 1986; 31: 661-4

  • Jeejeebhoy K. N., Chromium and perenteral nutrition, J. Trace Elem. Exp. Med., 1999; 12: 85-9

  • Cheng N. Z., Zhu X. X., Shi H. L., et al., Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium, J. Trace Elem. Exp. Med., 1999; 12: 55-60

  • Anderson R. A., Cheng N. Z., Bryden N. A., et al., Elevated intakes of supplemental chromium improve glucose and insulin variable in individuals with type 2 diabetes, Diabetes, 1997; 46: 1786-91

  • Anderson R. A., Polansky M. M., Bryden N. A., Canary J. J., Supplemental-chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets, Am. J. Clin. Nutr., 1991; 54: 909-916

  • Singh R. B., Rastogi S. S., Gupta R. K., Sharma V. K., Singh R. G., Can a diet rich in chromium and other minerals modulate blood sugar and blood lipids in noninsulin dependent diabetes mellitus?, 1992; 9: 157-162

  • Chausmer A. B., Zinc, insulin, and diabetes, J. Am. Coll. Nutr., 1998; 17: 109-15

  • El-Yazigi A., Hannan N., Raines D. A., Effect of diabetic state and related disorders on the urinary excretion of magnesium and zinc in patients, Diabetes Res., 1993; 22: 67-75

  • Blostein-Fujii A., DiSilvestro R. A., Frid D., Katz C., Malarkey W., Short-term zinc supplementation in women with non-insulin-dependent diabetes mellitus: Effects on plasma 5’-nucleotidase activities, insulin-like growth factor concentrations, and lipoprotein oxidation rates in vitro, Am. J. Clin. Nutr., 1997; 66: 639-41

  • Honnorat J., Accominotti M., Broussolle C., Fleuret A. C., Vallon J. J., Orgiazzi J., Effects of diabetes type and treatment on zinc status in diabetes mellitus, Biol. Trace Elem. Res., 1992; 32: 311-6

  • Brun F. F., Guintrand-Hugret R., Fons C., et al., Effects of oral zinc gluconate effectiveness and insulin sensitivity in humans, Biol. Trace Elem. Res., 1995; 47: 385-92

  • Lima M. D., Cruz T., Pousada J. C., Rodrigues L. E., Barbosa K., Canguçu V., The effect of magnesium supplementation in increased doses on the control of type 2 diabetes, Diabetes Care, 1998; 21: 682-6

  • Roffi M., Kanaka C., Mullis P. E., Peheim E., Blanchetti M. G., Hypermagnesiuria in choldren with newly diagnosed insulin-dependent diabetes mellitus, Am. J. Nephrol., 1994; 14: 201-6

  • Khan L. A., Alam A. M. S., Ali L., et al., Serum and urinary magnesium in young diabetic subjects in Bangladesh, Am. J. Clin. Nutr., 1999; 69: 70-3

  • Lowik M. R., Van Dokkum W., Kistemaker C., Schaafsma G., Ockhuizen T., Body composition, health status and urinary magnesium excretrion among elderly people (Dutch Nutrition Surveillance System), Magnes. Res., 1993; 6: 223-32

  • Maxwell S. R. J., Thomason H., Sandler D., et al., Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus, Eur. J. Clin. Invest., 1997; 27: 484-90

  • Nutall S. L., Dunne F., Kendall M. J., Martin U., Age-independent oxidative stress in elderly patients with non-insulin-dependent diabetes mellitus, Q. J. Med. 1999; 92: 33-8

  • Cunningham J. J., Micronutrients as nutriceutical intervention in diabetes mellitus, J. Am. Coll. Nutr., 1998; 17: 7-10

  • Gerster H., Prevention of platelet dysfunction by vitamin E in diabetic artheriosclerosis, Z. Ernahrungswiss., 1993; 32: 243-61

  • Kunisaki M., Umeda F., Inoguchi T., Wanatabe J., Nawata H., Effects of vitamin E administration on platelet function in diabetes mellitus, Diabetes Res., 1990; 14: 37-42

  • Tutüncü N. B., Bayraktar M., Varli K., Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes – A preliminary study, Diabetes Care, 1998; 21: 1915-8

  • Cariello A., Gliugliano D., Quatraro A., Donzella C., Dipalo G., Lefevre P. J., Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications?, Diabetes Care, 1991; 14: 68-72

  • Kahler W., Kuklinski B., Ruhlman C., Plotz C., Diabetes mellitus - a free radical-associated disease. Results of adjuvant antioxidant supplementation,
    Z. Gesamte Inn Med., 1993; 48: 223-32

  • Jain S. K., McVic R., Jaramillo J. J., Palmer M., Smith T., Effect of modest vitamin E supplementation on blood glycated hemoglobin and triglyceride levels and red indices in type 1 diabetic patients, Am. J. Coll. Nutr., 1996; 15: 458-61

  • Jain S. K., Krueger K. S., McVie R., Jaramillo J. J., Palmer M., Smith T., Relationship of blood thromboxane-B2 (TxB2) with lipid peroxidates and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients, Diabetes Care, 1998; 21: 1511-6

  • Jain S. K., Should high-dose vitamin E supplementation be recommended to diabetic patients?, Diabetes Care, 1999; 22: 1242-4

  • Som S., Basu S., Mukherjec D., et al., Ascorbic acid metabolism in diabetes mellitus, Metabolism, 1981; 30: 572-7

  • Ali S. M., Chakraborty S. K., Role of plasma ascorbate in diabetic microangiopathy, Bangladesh Med. Res. Counc. Bull., 1989; 15: 47-59

  • Amstrong A. M., Chestnutt J. E., Gormley M. J., Young I. S., The effect of diatery treatment on lipid peroxidation and antioxidant status in newly diagnosed noninsulin dependent diabetes, Free Radical Biol. Med., 1996; 21: 719-26

  • Chakraborty S. K., Plasma ascorbate status in newly diagnosed diabetics exhibiting retinopathy – a finding that alarms, Bangladesh Med. Res. Counc. Bull., 1992; 18: 30-5

  • Sinclair A. J., Taylor P. B., Lunec J., Girling A. J., Barnett A. H., Low plasma ascorbate levels in patients with type 2 diabetes mallitus consuming adequate dietary vitamin C., Diabet. Med., 1994; 11: 893-8

  • Pecoraro R. E., Chen M. S., Ascorbic acid metabolism in diabetes mellitus, Ann. N. Y. Acad. Sci., 1987; 498: 248-58

  • Cunningham J. J., Mearkle P. L., Brown R. G., Vitamin C: An aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes mellitus., J. Am. Coll. Nutr., 1994; 13: 344-50

  • Cunningham J. J., The glucose/insulin system and vitamin C: implications in insulin-dependent diabetes mellitus, J. Am. Coll. Nutr., 1998; 17: 105-8

  • McAuliffe A. V., Brooks B. A., Fisher E. J., Molyneaux L. M., Yuc D. K., Administration of ascorbic acid and aldose reductase inhibitor (tolrestat) in diabetics: Effect on urinary albumin excretion, Nephron, 1998; 80: 177-84

  • Wang H., Zhang Z. B., Wen R. R., Chen J. W., Experimental and clinical studies on the reduction of erythrocyte sorbitol-glucose ratios by ascorbic acid in diabetes mellitus, Diabetes Res., Clin. Pract., 1995; 28: 1-8

  • Eriksson J., Kohvakka A., Magnesium and ascorbic acid supplementation in diabetes mellitus, Ann. Nutr. Matab., 1995; 39: 217-23

  • Chevion S., Hofmann M., Ziegler R., Chevion M., Nawroth P. P., The antioxidant properties of thioctic acid: Characterization by cyclic volummetry, Biochem. Mol. Biol. Int., 1997; 317-27

  • Van Dam P. S., Bravenboer B., Oxidative stress and antioxidant treatment in diabetic neuropathy, Neurosci. Res. Commun., 1997; 21: 41-8

  • Haak E. S., Usadel K. H., Kohleisen M., Yilmaz A., Kusterer K., Haak T., The effect of α-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy, Microvasc. Res., 1999; 58: 28-34

  • Ziegler D., Gries F. A., Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy, Diabetes, 1997; 46 Suppl. 2: S62-S66

  • Chandra R. K., Nutrition and the immune system: An introduction, Am. J. Clin. Nutr., 1997; 66: 460S-3S

  • Erickson K. L., Medine E. A., Hubbard N. E., Micronutrients and immunity, J. Infect. Dis., 2000; 182: S5-S10

  • Lesourd B. M., Nutrition and immunity in the elderly: Modification of immune responses with nutritional treatments, Am. J. Clin. Nutr., 1997; 66: 478S-84S

  • Bogden J. D., Bendich A., Kemp F. W., et al., Daily micronutrient supplements enhance delayed-hypersensitivity skin test responses in older people, Am., J. Clin. Nutr., 1994; 60: 437-47

  • Semba R. D., Vitamin A, immunity, and infection, Clin. Infect. Dis., 1994; 19: 489-99

  • Underwood B. A., Hypovitaminosis A: International programmatic issues, J. Nutr., 1994; 124 Suppl.: 1467S-72S

  • Stephensen C. B., Alvarez J. O., Kohatsu J., Hardmeier R., Kennedy J. I. Jr., Gammon R. B. Jr., Vitamin A is excreted in the urine during acute infection, Am. J. Clin. Nutr., 1994; 60: 388-92

  • Bendich A., Beta-caroten and immune response, Proc. Nutr. Soc., 1991; 50: 263-74

  • Hughes D. A., Wright A. J., Finglas P. M., et al., The effect of beta-carotene supplementation on the immune function of blood monocytes from healthy male nonsmokers, J. Lab. Clin. Med., 1997; 129: 309-17

  • Santos M. S., Gaziano J. M, Leka L. S., Beharka A. A., Hennekens C. H., Meydani S. N., Beta-carotene-induced enhancement of natural killer cell activity in elderly men: an investigation of the role of cytokine, Am. J. Clin. Nutr., 1998; 68: 164-170

  • Watson R. R., Prabhala R. H., Plezia P. M., Alberts D. S., Pike J., Chandra R. K., Effect of beta-caroten on lymphocyte subpopulations in elderly humans: evidence for a dose-response relationship. Effect of vitamin and trace element supplementation on immune indices in healthy elderly, Am. J. Clin. Nutr., 1991; 53: 90-4

  • De La Fuente M., Ferrández M. D., Burgos M. S., Soler A., Prieto A., Miquel J., Immune function in aged women is improved by ingestion of vitamins C and E, Can. J. Physiol. Pharmacol., 1998; 76: 373-80

  • Hemila H., Vitamin C and common cold incidence: a review of studies with subjects under heavy physical stress, Int. J. Sports Med., 1996; 17: 379-83

  • Hemila H., Vitamin C intake and susceptibility to the common cold, Br. J. Nutr., 1997; 77: 59-72

  • Hunt C., Chakravorty N. K., Annan G., Habibzadeh N., Schorah C. J., The clinical effects of vitamin C supplementation in elderly hospitalized patients with acute respiratory infections, Int. J. Vitam. Nutr. Res.,1994; 64: 212-9

  • Jayachandran M., Panncerselvam C., Cellular immune responses to vitamin C supplementation in aging humans by the in vitro leucocyte migration inhibition test, Med. Sci. Res., 1998; 26: 227-30

  • Peters E. M., Goetzche J. M., Grobelaar B., Noakes T. D., Vitamin C supplementation reduces the incidence of postrace symptoms of upper-respiratory-tract infection in ultramarathon runners, Am. J. Clin. Nutr., 1993; 57: 170-4

  • Wilson C. W., Greene M., Loh H. S., The metabolism of supplementary vitamin C during the common cold, J. Clin. Pharmacol., 1976; 16: 19-29

  • Meydani S. N., Beharka A. A., Recent developments in vitamin E and immune response, Nutrition reviews, 1998; 56: S49-S58

  • Serafini M., Dietary vitamin E and T-call-mediated function in the elderly: effectiveness and mechanism of action, Int. J. Dev. Neurosci, 2000; 18: 401-10

  • Meydani S. N., Meydani M., Blumberg J. B., et al., Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial, JAMA, 1997; 277: 1380-6

  • Chavance M., Herbeth B., Fournier C., Janot C., Vernhes G., Vitamin status, immunity, and infections in an elderly population, Eur. J. Clin. Nutr., 1989; 43: 827-35

  • Bates C. J., Pentieva K. D., Prentce A., Mansoor M. A., Finch S., Plasma pyridoxal phosphate and pyridoic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over, Br. J. Nutr., 1999; 81: 191-201

  • Meydani S. N., Ribaya-Mercado J. D., Russell R. M., Sahyoun N., Morrow F. D., Gershoff S. N., Vitamin B6 deficiency impairs interleukin 2 production and lymphacyte proliferation in elderly adults, Am. J., Clin. Nutr., 1991; 53: 1275-80

  • Talbott M. C., Miller L. T., Kerkvliet N. I., Pyridoxine supplementation: effect on lymphocyte responses in elderly persons, Am. J. Clin. Nutr., 1987; 46: 659-64

  • Folkers K., Morita M., McRee J. Jr., The activities of coenzyme Q10 and vitamin B6 for immune responses, Biochem. Biphys. Res. Commun., 1993; 193: 88-92

  • Keen C. L., Gershwin M. E., Zinc deficiency and immune function, Annu. Rev. Nutr., 1990; 10: 415-31

  • Brignola C., Belloli C., De Simone G., et al., Zinc supplementation restores concentrations of zinc and thymulin in patients with Crohn’s disease, Aliment. Pharmacol. Ther., 1993; 7: 275-80

  • Gupta R. K., Bhattachatya S. K., Sundar S., Kumar K., Kachhawaha J. S., Sen P. C., A correlative study of serum zinc and in vivo cell mediated immune status in rheumatic heart disease, Acta Cardiol., 1996; 47: 297-304

  • Sherman A. R., Zinc, copper, and iron nutriture and immunity, J. Nutr., 1992; 122: 604-9

  • Mei W., Dong Z. M., Liao B. L., Xu H. B., Study of immune function of cancer patients infuenced by supplemental zinc or selenium-zinc combinatiom, Biol. Trace Elem. Res., 1991; 28: 11-9

  • Shankar A. H., Prasad A. S., Zinc and immune function: the biological basis of altered resistance to infection, Am. J. Clin. Nutr., 1998; 68: 447S-63S

  • Wellinghausen N., Kirchner H., Rink L., The immunobiology of zinc, Immunol. Today, 1997; 18: 519-21

  • Prasad A. S., Zinc and immunity, Mol. Cell. Biochem., 1998; 188: 63-9

  • Mazzotta M. Y., Nutrition and wound healing, J. Am. Podiatr. Med. Assoc., 1994; 84: 456-62

  • Sun E., Xu H., Liu Q., Zhou J., Zuo P., Wang J., The mechanism for the effect of selenium supplementation on immunity, Biol. Trace Elem. Res., 1995; 48: 231-8

  • Roy M., Kiremidjian-Schumacher L., Wishe H. I., Cohen M. W., Stotzky G., Supplementation with selenium restores age-related decline in immune cell function, Proc. Soc. Exp. Biol. Med., 1995; 209: 369-75

  • Rayman M. P., The importance of selenium to human health, Lancet, 2000; 356: 233-41

  • Taylor E. W., Selenium and cellular ummunity – Evidence that selenoproteines may be encoded in the + 1 reading frame overlapping the human CD4, CD8, and HLA-DR genes, Biol. Trace Elem. Res., 1995; 49: 85-95

  • Levander O. A., Beck M. A., Selenium and viral virulance, Br. Med. Bull., 1999; 55: 528-33

  • Beck M. A., Nutritionally induced oxidative stress: effct on viral disease, Am. J. Clin. Nutr., 2000; 71: 1676S-9S

  • Forceville X., Vitoux D., Gauzit R., Combes A., Lahilaire P., Chappuis P., Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients, Crit. Care Med., 1998; 26: 1536-44

  • Girodon F., Lombard M., Galan P., et al., Effect of micronutrient supplementation on infection in institutionalized elderly subjects: A controlled trial, Ann. Nutr. Metab., 1997; 41: 98-107

  • Goldbloom R., Battista G., et al., Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects, Can. Med. Assoc. J., 1994; 151: 159-66

  • Daly S., Mills J. L., Molloy A. M., et al., Minimum effective dose of folic acid for food fortification to prevent neural-tube defects, Lancet, 1997; 350: 1666-9

  • Berry R. J., Li Z., Erickson J. D., et al., Prevention of neural defects with folic acid in China, N. Engl. J. Med., 1999; 341: 1485-90

  • Werler M. M., Hayes C., Louik C., Shapiro S., Mitchell A. A., Multivitamin supplementation and risk of birth defects, Am. J. Epidemiol, 1999; 150: 675-82

  • Seddon J. M., Ajani U. A., Sperduto R. D., et al., Dietary carotenoids, vitamin A, C, and E, and advanced age-related macular degeneration, Eye Disease Case-Control Study Group, JAMA, 1994; 272: 1413-20

  • Berendschot T. T. J. M., Goldbohm R. A., Klöpping W. A. A., Van de Kraats J., Van Norel J., Van Norren D., Influence of lutein supplementation on macular pigment, assessed with two objective techniques, Invest. Opthalmol. Vis. Sci., 2000; 41: 3322-6

  • Bone R. A., Landrum J. T., Dixon Z., Chen Y., Llrena C. M., Lutein and zeaxanthin in the eyes, serum, and diet of human subjects, Exp. Eye Res., 2000; 71: 239-45

  • Brown L., Rimm E. B., Seddon J. M., et al., A prospective study of carotenoid intake and risk of cataract extraction in U.S. men, Am. J. Clin. Nutr., 1999; 70: 517-24

  • Chasan-Taber L., Willett W. C., Seddon J. M., et al., A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in U.S. women, Am. J. Clin. Nutr., 1999; 70: 509-16

  • Moeller S. M., Jacques P. F., Blumberg J. B., The potential role of dietary xanthophylls in cataract and age-related macular degeneration, J. Am. Coll. Nutr., 2000; 19: 522S-7S

  • Pratt S., Dietary prevention of age-related macular degeneration, J. Am. Optom. Assoc., 1999; 70: 39-47

  • Yeum K. J., Shang F., Schalch W., Russell R. M., Taylor A., Fat-soluble nutrient concentrations in fifferent layers of human cataractous lens, Curr. Eye Res., 1999; 19: 502-5

  • Gerster H., Antioxidant vitamins in cataract prevention, Z. Ernahrungswiss., 1989; 28: 56-75

  • Jacques P. F., Chylack L. T. J., Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention, Am. J. Clin. Nutr., 1991; 53: 352S-5S

  • Belda J. I., Romá J., Vilela C., et al., Serum vitamin E levels negatively correlate with severity of age-related macular degeneration, Mech. Aging Dev., 1999; 107: 159-64

  • Delcourt C., Cristol J. P., Tessler F., et al., Age-related macular degeneration and antioxidant status in the POLA study, Arch. Opthamol., 1999; 117: 1384-90

  • Lyle B. J., Mares-Perlman J. A., Klein B. E., et al., Serum carotenoids and tocopherols and incidence of age-related nuclear cataract, Am. J. Clin. Nutr., 1999; 69: 272-7

  • Seth R. K., Kharb S., Protective function of alpha-tocopherol against the process of cataractogenesis in humans, Ann. Nutr. Metab., 1999; 43: 286-9

  • Hathcock J. N., Vitamin and Mineral Safety, 1997, Washington, D. C., Council for Responsible Nutrition

  • Food and Nutrition Board and Institute of Medicine. Dietary Reference Intakes for Vitamn C, Vitamin E, Selenium, and Carotenoids, (Advance Copy), 2000, Washington, D. C., National Academy Press

  • Food and Nutrition Board and Institute of Medicine. Dietary Reference Intakes: Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Panthotenic Acid, Biotin, and Choline, Republication Copy, 1998, Washington, D. C., National Academy Press

  • Thomas J. A., Drug-nutrient interactions, Nutr. Rev., 1995; 53: 271-82

  • Matsui M. S., Rozovski S. J., Drug-nutrient interaction, Clin. Ther., 1997; 4: 423-40

  • Anderson P., Godal H. C., Predictable reduction in anticoagulant activity of warfarin by small amounts of vitamin K, Acta Med. Scand., 1975; 198: 269-70

  • Karlson B., Leijd B., Hellstrom K., On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment, Acta Med. Scand., 1986; 220: 347-50

  • Booth S. L., Charnley J. M., Sadowski J. A., Saltzman E., Bovill E. G., Cushman M., Dietary vitamin K1 and stability of oral anticoagulation: proposal of a diet with constant vitamin K1 content, Thrombosis and Haemostasis, 1997; 77: 504-9

  • Sorano G. G., Biondi G., Conti M,., Mameli G., Licheri D., Marongiu F., Controlled vitamin K content diet for improving the management of poorly controlled anticoagulated patients: a clinical practice proposal, Haemostsis, 1993; 23: 77-82
  • 1   2   3   4   5


    ©absta.pl 2016
    wyślij wiadomość

        Strona główna